24 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Jul 11, 04:01 PM
ABL Biotechnologies Ltd.

BSE

  • 0.81 0.00 (0%)
  • Vol: 37663
  • BSE Code: 526955
  • PREV. CLOSE
    0.81
  • OPEN PRICE
    0.80
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    0.00(0)

NSE

  • (%)
  • Vol:
  • NSE Code:
  • PREV. CLOSE
  • OPEN PRICE
  • BID PRICE (QTY.)
    ()
  • OFFER PRICE (QTY.)
    ()

ABL Biotechnologies Ltd. Financial Ratios

Particulars
Mar 2012
Mar 2011
Operational & Finanial Ratios
 
 
   Reported EPS(Rs)
-0.22  
-0.73  
   Adjusted EPS(Rs)
-0.22  
-0.73  
   CEPS(Rs)
-0.14  
-0.64  
   DPS(Rs)
0.00  
0.00  
   Book NAV/Share(Rs)
17.61  
17.77  
   Tax Rate(%)
0.00  
0.00  
Margin Ratios
 
 
   Core EBITDA Margin(%)
NA  
-1266.04  
   EBIT Margin(%)
NA  
-1423.25  
   Pre Tax Margin(%)
NA  
-1424.99  
Performance Ratios
 
 
   ROA(%)
-0.40  
-1.32  
   ROE(%)
-1.24  
-4.11  
   ROCE(%)
-0.56  
-1.90  
   Asset Turnover(x)
0.00  
0.00  
   Sales/Fixed Asset(x)
0.00  
0.00  
   Working Capital/Sales(x)
0.00  
-0.01  
Efficiency Ratios
 
 
   Fixed Capital/Sales(x)
NA  
849.97  
   Receivable days
NA  
2745.81  
   Inventory Days
NA  
0.00  
   Payable days
0.00  
0.00  
Valuation Parameters
 
 
   PER(x)
0.00  
0.00  
   PCE(x)
-36.19  
-13.71  
   Price/Book(x)
0.28  
0.50  
   Yield(%)
0.00  
0.00  
   EV/Net Sales(x)
NA  
572.99  
   EV/Core EBITDA(x)
-191.01  
-45.59  
   EV/EBIT(x)
-118.18  
-40.26  
   EV/CE(x)
0.46  
0.53  
Growth Ratio
 
 
   Net Sales Growth(%)
-100.00  
0.00  
   Core EBITDA Growth(%)
79.18  
0.00  
   EBIT Growth(%)
70.29  
0.00  
   PAT Growth(%)
70.07  
0.00  
   Adj PAT Growth(%)
70.07  
0.00  
   Adj EPS Growth(%)
70.06  
0.00  
Financial Stability Ratios
 
 
   Total Debt/Equity(%)
1.18  
1.16  
   Current Ratio(x)
0.63  
0.63  
   Quick Ratio(x)
0.63  
0.63  
   Interest Cover(x)
-114.14  
-818.17  
   Total Debt/Mcap(%)
4.24  
2.34